Stock comparison

JAZZvsLLY

Jazz Pharmaceuticals PLCvsEli Lilly and Co. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

JAZZ

Jazz Pharmaceuticals PLC

$199.96

+17.95%

Pharmaceuticals$11.5BNASDAQ

LLY

Eli Lilly and Co

$917.65

-12.96%

Pharmaceuticals$884.0BNYSE

60-day price, rebased to 100

JAZZ +21.94% · LLY -11.52%

Round-by-round

JAZZ 2·LLY 4

EdgeJAZZ

Valuation upside

-5.90% vs -70.70% to DCF fair value

EdgeLLY

Balance-sheet strength

Altman Z 1.73 vs 8.14

EdgeLLY

Fundamental quality

Piotroski 5.00 vs 8.00 (of 9)

EdgeLLY

Growth + margins

Rule-of-40 31.70 vs 53.90

EdgeJAZZ

60-day momentum

+21.94% vs -11.52% price return

EdgeLLY

Market-cap liquidity

$11.5B vs $884.0B

Verdict

Across6categories,LLYtakes the edge with4wins to2. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onJAZZorLLY

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.